by Cliff Corcoran |
November 13, 2008 3:00 am |
8 Comments
The Yankees have signed their first Type A free agent of the offseason, re-upping lefty reliever Damaso Marte, whose $6 million option they had declined just last week, with a three-year deal worth $12 million with a club option for 2012. Marte joined the Yankees just before the trading deadline this year in the deal that also brought Xavier Nady over from the Pirates.
Marte’s Yankee career didn’t get off to the best start as he struggled in two of his first five outings for the Bombers, allowing six runs in his first 4 2/3 innings. His fifth Yankee appearance saw him throw 42 pitches in 101-degree heat in Texas. Marte hadn’t thrown that many pitches in a single outing since August 2006 and promptly developed discomfort in his pitching elbow. Four outings later, Marte turned in another stinker, setting his Yankee ERA at 11.05 after nine appearances. Though Joe Girardi insisted that there was nothing wrong with the Dominican lefty, Marte faced just one batter over the next nine days, eventually informing the media of his elbow discomfort on his own.
The time off did trick as Marte returned to action on August 22 and posted a 1.64 ERA over his last 15 appearances, striking out 13 in 11 innings, while allowing just nine baserunners. The Yankees have clearly chosen to focus on those last 15 outings rather than on the first nine and that bit of elbow pain.
By declining Marte’s option only to resign him to a multi-year deal, the Yankees have done exactly what many expected they would, though I’m troubled by the length of the deal, particularly given that Marte will turn 34 before pitchers and catchers report. Perhaps the most significant success of the 2008 Yankees was their ability to piece together one of the best bullpens in baseball from an assemblage of home-grown arms and minor league free agents. Perhaps just as impressively, they were able to replace parts on the fly when, for example, Brian Bruney broke his foot, or Joba Chamberlain moved into the rotation.
That success seemed to teach the Yankees all they needed to know about the fungibility of relief pitchers, prompting them to release struggling veteran LaTroy Hawkins, whose signing last winter seemed like little more than a hedge against betting the pen on those other unproven arms, and trade Kyle Farnsworth, the lone big-money holdover from past failed attempts to buy a better bullpen, in the wake of the acquisition of Marte. When Marte struggled in his first month as a Yankee without doing much damage to the pen as a whole, that seemed to provide another lesson. Still, here we are again, evaluating a three-year deal for a veteran set-up reliever.
I would have understood if the Yankees had picked up Marte’s option, using him as a hedge against coming set-up man Mark Melancon or against a second look at lefty Phil Coke in the major league pen. I would have understood a two year deal at a reduced salary, which would have allowed the team to trade Marte either at the deadline or next winter. Three years plus an option? That I don’t get. Not when the option would be for Marte’s age-37 season. Not given that bit of elbow trouble in August. Not given all of the pitching already in the Yankee system.
(more…)